S&P Global, the world’s leading authority of ESG ratings and research, recently released “The S&P Global Sustainability Yearbook 2026.” Microbio Group delivered an outstanding performance: its subsidiary Oneness Biotech Co., Ltd. (4743) has been selected for the fourth consecutive year, while Diamond BioFund Inc. (6901) and Microbio Co., Ltd. (4128) made their debut on the...Read More
發布日期：2025-12-09 原始連結：https://pharmaboardroom.com/interviews/yenchen-huang-head-of-investment-vp-diamond-biofund-taiwan/ PHARMA BOARDROOM｜2025.12.09 We describe ourselves as “entrepreneurs behind entrepreneurs” – not merely passive capital providers but active partners throughout the journey. Yenchen Huang – Head of Investment & VP, Diamond Biofund, Taiwan How does dual scientific and investment expertise shape investment decisions at Diamond Biofund? Diamond Biofund’s investment...Read More
December 8, 2025 PRNewswire NES ZIONA, Israel, Dec. 8, 2025 /PRNewswire/ — EyeYon Medical Ltd., a global leader in ophthalmic innovation, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to initiate a U.S. clinical study of EndoArt®, the world’s first synthetic endothelial layer for the treatment of chronic corneal edema. EndoArt®...Read More
October 29, 2025 | Wednesday | News Existing technologies have struggled to fully unlock the proteome of the cell plasma membrane, which governs how molecules enter, exit, and signal within cells Syncell Inc., US and Taiwan based nanoscopic proteomics company, has announced the launch of its Synlight-Pure™ Kit, an ultra-high-precision photolabeling reagent for...Read More
Oct 14, 2025 8:03 AM Eastern Daylight Time Scientists at Max Planck Institute of Biochemistry and VIB are deploying Microscoop® Mint technology to gain the most precise and unbiased view of subcellular protein activity LIVERMORE, Calif. & TAIPEI, Taiwan–(BUSINESS WIRE)–Syncell Inc., a leader in next-generation unbiased subcellular proteomics analysis, today announced the deployment of...Read More
2025 / 08 / 14News Company joins forces with Thermo Fisher Scientific to develop integrated workflow combining Syncell’s Microscoop technology and Thermo Fisher’s Orbitrap Astral mass spectrometer series LIVERMORE, Calif., and TAIPEI, Taiwan — August 14, 2025 — Syncell, Inc., a pioneer in subcellular spatial proteomics, announced a strategic co-marketing agreement with Thermo Fisher...Read More
Apr 24, 2025 8:00 Businesswire New relationships with Cold Spring Biotech, SCRUM and DaonBS in APAC will enable many more laboratories to adopt Syncell technology TAIPEI, Taiwan & LIVERMORE, Calif.–(BUSINESS WIRE)–Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, announced the launch of their preferred partner network today. The company’s commercial expansion...Read More
Published: 2025-05-05 On April 30, the Taiwan Stock Exchange (TWSE) announced the results of the 11th Corporate Governance Evaluation for 2024. Diamond Biofund Inc. (6901), in its first year of participation, was recognized among the top 5% of TWSE-listed companies. Meanwhile, Microbio Co., Ltd. (4128) and Oneness Biotech Co., Ltd. (4743)—both members of the Microbio...Read More
Published: 2025-03-20 News provided by EyeYon Medical 20 Mar, 2025, 11:00 IST NES ZIONA, Israel, March 20, 2025 /PRNewswire/ — EyeYon Medical, a global leader in innovative corneal implant solutions, is proud to announce that Dr. Ofer Daphna, the inventor of EndoArt®, will deliver an invited keynote lecture at the prestigious World Cornea Congress (WCC)...Read More
03-18-2025 BY Adam Bluestein The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech companies reflects the evolving impact of AI, a growing interest in cutting-edge research tools for single-cell analysis and spatial proteomics,...Read More
